La Jolla Pharmaceutical Co.

The LJPC stock trades on Nasdaq All Markets

united states of america therapeutics micro-cap septic or other distributive shock intra-abdominal infections

Company Description

La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases.

Drug Pipeline

Source: La Jolla Pharmaceutical Co. - 20220930

Asset

Indication

Pre-Clinical

Ph1

Ph2

Ph3

Reg/Com

Phase

GIAPREZA

Septic Shock

Reg/Com

XERAVA

Intra-Abdominal Infections

Reg/Com

Conversation

0 following

0 Comments on LJPC stock

Newest